Today: 16 July 2026
3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery
9 March 2026
2 mins read

3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

Rock Hill, South Carolina — March 9, 2026, 09:14 EDT

3D Systems reported Monday that fourth-quarter revenue climbed 16% sequentially to $106.3 million, topping its internal forecast as both printer deliveries and materials usage improved. The 3D-printing firm still flagged a fresh quarterly loss ahead and noted that full-year revenue slipped 12% from 2024 levels.

That’s a key point now, as 3D Systems has spent the last year slashing costs and diving further into medical, dental, and aerospace sectors—an adjustment after sluggish customer spending on new factory gear dragged down demand. Stratasys and Materialise, both rivals in additive manufacturing (the sector’s name for 3D printing built up layer by layer), are shifting into the same production and healthcare specialties.

3D Systems outpaced its own November guidance for 8% to 10% sequential growth this quarter. Still, revenue dipped 4% versus last year. Healthcare Solutions climbed 25% to $50.5 million, but Industrial Solutions slid 21%, coming in at $55.8 million.

Chief Executive Jeffrey Graves called the quarter “exceeded our expectations,” pointing to med tech, dental and aerospace as areas “rapidly adopting 3D printing.” Those sectors sit right at the heart of the company’s latest product cycle. Q4 Capital

Interim CFO Phyllis Nordstrom said 3D Systems is still “intensely focused on reducing overall spending,” noting the company has already locked in about $55 million in annualized savings for 2025. Nordstrom pointed out that a debt-for-equity swap pushed most of the company’s debt originally set to mature in late 2026 out to 2030. That leaves just $3.9 million coming due in the fourth quarter of 2026, with $92 million now scheduled for 2030. Q4 Capital

Revenue for the full year slid to $386.9 million, down from $440.1 million. GAAP net income landed in the black at $29.9 million, a shift the company chalked up mostly to asset sale gains, lower costs, and reduced impairment charges. Still, adjusted EBITDA—a metric that strips out certain items—remained negative, posting a $45.4 million loss.

Risks remain obvious. 3D Systems is guiding for first-quarter revenue between $91 million and $94 million, with adjusted EBITDA projected in the red—negative $5 million to negative $3 million—worse than the prior quarter. Gross margin slipped to 30.8%. Cash and cash equivalents fell sharply to $95.6 million, down from $171.3 million a year ago. The company’s earlier aim to achieve break-even or better on adjusted EBITDA by the end of 2025 has fallen off track.

Take out Geomagic—the software suite 3D Systems offloaded to Hexagon for $123 million in April 2025—and the numbers tighten up. The firm pegged comparable fourth-quarter 2024 revenue at $103.3 million. That’s still under the most recent quarter’s $106.3 million.

It’s a mixed picture for the sector. Stratasys disclosed last week that manufacturing accounted for 37.5% of revenue, but flagged that tariffs and currency moves might shave roughly $17 million off 2026 earnings. Over at Materialise, the medical division posted 16.3% fourth-quarter growth.

3D Systems is leaning on sectors with deeper budgets. The company reported a 16% jump in aerospace and defense revenue for 2025, saying it’s aiming for 20% growth in that slice in 2026. Custom medical planning, implants, and dental products—those are still the key engines for expansion.

The next update lands soon. Fourth-quarter printer shipments need to translate into the pricier materials and service sales that 3D Systems is banking on after those machines are deployed.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Coca-Cola Approaches 52-Week High as Consumer Staples Outperform
    July 16, 2026, 4:32 PM EDT. Coca-Cola (NYSE: KO) advanced 2.6% to $84.63, moving close to its 52-week high as consumer staples stocks outperformed. The Consumer Staples Select Sector SPDR Fund climbed 2.6% while the S&P 500 ETF slipped 0.7%. With a dividend yield of 2.5%, Coca-Cola continues to draw defensive investors, even as the 10-year Treasury yield hits 4.59%. The stock trades at a premium trailing price-to-earnings ratio compared with PepsiCo and Keurig Dr Pepper. Market participants are looking ahead to Coca-Cola's Q2 results on July 28, after strong Q1 volume and earnings. Potential challenges remain from higher oil prices and increased borrowing costs, which could impact demand and margins.
Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Previous Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets
Next Story

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets

Go toTop